* Alignment Healthcare Inc ALHC.OQ ALHC.O is expected
to show
a rise in quarterly revenue when it reports results on February
27 for the period ending December 31 2023
* The Orange California-based company is expected to report
a
22.9% increase in revenue to $444.602 million from $361.81
million a year ago, according to the mean estimate from 10
analysts, based on LSEG data.The company's guidance on November
2 2023, for the period ended December 31, was for revenue
between $422.00 million and $442.00 million.
* LSEG's mean analyst estimate for Alignment Healthcare Inc
is
for a loss of 22 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Alignment
Healthcare Inc is $10.00, above its last closing price
of $6.28.
The company's guidance on November 2 2023 for the period ended
December 31 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between 422 million and -10
million (USD).
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.18 -0.18 -0.18 Met 1.4
Jun. 30 2023 -0.21 -0.22 -0.15 Beat 31.4
Mar. 31 2023 -0.26 -0.25 -0.20 Beat 21.4
Dec. 31 2022 -0.30 -0.30 -0.31 Missed -4.3
Sep. -0.24 -0.25 -0.22 Beat 10.5
30 2022
Jun. 30 2022 -0.26 -0.26 -0.06 Beat 76.7
Mar. 31 2022 -0.25 -0.25 -0.23 Beat 6.5
Dec. 31 2021 -0.31 -0.30 -0.27 Beat 9.6
This summary was machine generated February 24 at 03:08 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)